EPO doping in elite cycling: No evidence of benefit, but high risk of harm

December 5, 2012, Wiley

The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete's performance and give people who use it an unfair advantage over unenhanced competitors. However a new systemic review of existing research, published in the British Journal of Clinical Pharmacology, reveals that there is no scientific evidence that it does enhance performance, but there is evidence that using it in sport could place a user's health and life at risk.

Professional cycling is a popular sport, but over the last decades the sport's image has been tainted by high-profile doping cases. EPO, a blood-cell stimulating hormone, has recently made headlines, with the United States of America's anti-doping agency (USADA) claiming that it was used by record seven-time winner Lance Armstrong.

"Athletes and their may believe EPO enhances performance, but there is no evidence that anyone performed good experiments to check if EPO would actually improve performance in elite cyclists," says lead researcher Professor Adam Cohen, who works at the Centre for Human Drug Research in Leiden, The Netherlands.

On the other hand, the possible harm is well documented. EPO thickens a person's blood, which can lead to an increased risk of clots. These clots obstruct blood flow to areas of tissue, and so oxygen doesn't get to the cells and they die, damaging the organ. If the organ is your heart or your brain this can be particularly dangerous, potentially resulting in or stroke.

Normally EPO is used in medicine to treat people with , where its effect on each patient is carefully monitored. Professor Cohen points out that researchers work hard to prevent patients taking drugs that don't work or have dangerous side-effects. "So why should the standards be different for the same drugs used in athletes?" he asks.

"Although doping is forbidden, the pressure to win in sport is so great that some athletes seem to be willing to try any way of getting ahead of their competitors. When elite athletes and their coaches discover that there is no evidence of benefit and clear risk of harm, I hope many may reconsider trying to cheat. Education may work where attempts at enforcement have failed," says Cohen.

"I believe there is a clear need for high-quality research to investigate the effects of supposedly enhancing drugs in sport. If, as is expected, many substances in current use are found to be ineffective it will help keep our athletes safe and improve confidence in sporting results," says Cohen.

Explore further: The doping-drug Epo has an impact in the brain

More information: Heuberger J, Cohen Tervaert J, Schepers F, Vliegenthart B, Rotmans J, Daniels J, Burggraaf J, Cohen A. Erythropoietin doping in cycling: Lack of evidence for efficacy and a negative risk-benefit. British Journal of Clinical Pharmacology. 2012; DOI: 10.1111/bcp.12034

Related Stories

The doping-drug Epo has an impact in the brain

June 11, 2012
Sportsmen and women dope with the blood hormone Epo to enhance their performance. Researchers from the University of Zurich now discovered by animal testing that Epo has a performance-enhancing effect in the brain shortly ...

As Armstrong case unfolds, experts describe doping's harms

October 11, 2012
(HealthDay)—In the wake of new allegations around Lance Armstrong's involvement in blood doping, experts are reminding the public of the devastating impact these substances can have on an athlete's health.

Biker's warning! Erythropoietin hits blood vessels to raise blood pressure in the brain

December 10, 2011
Erythropoietin or EPO might be considered a "performance enhancing" substance for athletes, but new research published online in The FASEB Journal shows that these enhancements come at a high cost--increased risk of vascular ...

EPO doping helps combat cerebral malaria

April 21, 2011
Almost 3.3 billion people, half of the world's population, risk being infected with malaria. Despite having effective means against malaria, the WHO reports 250 million cases of malaria each year and more than 700,000 related ...

Recommended for you

Women run faster after taking newly developed supplement, study finds

January 19, 2018
A new study found that women who took a specially prepared blend of minerals and nutrients for a month saw their 3-mile run times drop by almost a minute.

Americans are getting more sleep

January 19, 2018
Although more than one in three Americans still don't get enough sleep, a new analysis shows first signs of success in the fight for more shut eye. According to data from 181,335 respondents aged 15 and older who participated ...

Wine is good for you—to a point

January 18, 2018
The Mediterranean diet has become synonymous with healthy eating, but there's one thing in it that stands out: It's cool to drink wine.

Sleep better, lose weight?

January 17, 2018
(HealthDay)—Sleeplessness could cost you when it's time to stand on your bathroom scale, a new British study suggests.

Who uses phone apps to track sleep habits? Mostly the healthy and wealthy in US

January 16, 2018
The profile of most Americans who use popular mobile phone apps that track sleep habits is that they are relatively affluent, claim to eat well, and say they are in good health, even if some of them tend to smoke.

Improvements in mortality rates are slowed by rise in obesity in the United States

January 15, 2018
With countless medical advances and efforts to curb smoking, one might expect that life expectancy in the United States would improve. Yet according to recent studies, there's been a reduction in the rate of improvement in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.